SLGL Stock — Sol Gel Technologies Ltd

Sol Gel Technologies Ltd (SLGL)

Updated October 16, 2026.

SLGL is a Stock. Total return is -52.9% over the past 8.7 years, 262.4 points behind SPY at 209.5%.

Sol-Gel Technologies Ltd. is a biopharmaceutical company headquartered in Israel that develops topical dermatological treatments for severe skin conditions. The company markets Twyneo for acne vulgaris and Epsolay for rosacea, while advancing pipeline candidates including SGT-610 for Gorlin Syndrome and SGT-210 for Olmsted Syndrome through clinical development. The company does not currently distribute income to shareholders and appeals primarily to investors seeking exposure to specialty pharmaceutical development rather than dividend income.

SLGL performance versus SPY

Price and return data through 2026-10-16.

Total return is -52.9% over the past 8.7 years, 262.4 points behind SPY at 209.5%. Over the past year its total return — price change plus distributions reinvested — is 58.6%. Its deepest 1-year drawdown was 39.5%.

SLGL key facts

Asset type

Stock

Asset class

Equity

Inception date

02/01/2018

Distribution frequency

None

Last close

$64.25 (as of 2026-10-16)

Market cap

$210,354,436

Average volume

69824.0

Beta

1.15

Payout ratio

0.0%

Forward P/E

9.3371

EPS

$-5.61

How Dividend Vision calculates yield and returns

Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

SLGL risks and drawbacks

Total return has trailed SPY over the available window. The deepest 1-year drawdown on record here is 39.5%.

Who may consider SLGL — and who may not

It is a weaker fit for investors who need monthly cash flow (SLGL does not currently distribute); investors whose main goal is matching SPY total return. This is educational context, not a recommendation to buy or sell.

More on SLGL

• All tickers starting with S

Tagged: Healthcare.

Frequently asked questions